Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
BeiGene
>>
Phase 1
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
lifirafenib
(BGB-283) / BeiGene
tapotoclax
(AMG 176) / Amgen
ABI-H3733
/ Assembly Biosci, BeiGene
BGB-23339
/ BeiGene
BGB-B167
/ BeiGene
IGM-6268
/ Atreca, BeiGene, IGM Biosciences
sovilnesib
(AMG 650) / Volastra Therap
zanidatamab zovodotin
(ZW49) / Zymeworks
BGB-24714
/ BeiGene
BITR2101
/ Boston Immune Tech
MP0310
/ Molecular Partners
SEA-CD70
/ Pfizer
emirodatamab
(AMG 427) / Amgen
inezetamab
(AMG 994) / Amgen, BeiGene
latikafusp
(AMG 256) / Amgen
vepsitamab
(AMG 199) / Amgen
xaluritamig
(AMG 509) / Amgen
